News
In the latest instalment of a long-running dispute, the Court of Appeal has recently upheld the High Court judge's view on whether the Defendants had breached the terms of an order made in July 2020, ...
Tapfiliate - How to Attract and Retain the Best Affiliate Publishers: a 6-Step Guide for Advertisers
Attracting quality publishers takes more than just a signup form. Smart visibility, trust-building, and consistent follow-through - this is what works. Here's a 6-step guide based on what's worked for ...
Despite indications that a single dose of Merck's (NYSE:MRK) human papillomavirus vaccine Gardasil could be as effective as the current multi-dosing schedule, the drugmaker said that an ...
Veeva Systems today released the latest insights from its Veeva Pulse Field Trends Report, showing effective content-driven ...
Merck – known as MSD outside the US and Canada – hasn't broken down the payments but said they include an upfront payment plus development, regulatory and commercialization milestones.
Cancer Surveillance in the United States in Jeopardy: Leveraging 21st Century Technology to Enhance Public Health Patients age 20 years and older with AGC, who had experienced disease progression ...
Competition from the bispecifics could be a big deal for MSD – known as Merck & Co in the US and Canada – given that Keytruda contributed $25 billion of its $60.1 billion global sales last year.
TME Pharma N.V. (Euronext Growth Paris: ALTME),a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...
Lifehacker has been a go-to source of tech help and life advice since 2005. Our mission is to offer reliable tech help and credible, practical, science-based life advice to help you live better ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...
More Bonds of MSD Netherlands Capital B.V. Moody’s Daily Credit Risk Score About the MSD Netherlands Capital B.V.-Bond (XS2825485183) The MSD Netherlands Capital B.V.-Bond has a maturity date of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results